Jane Street’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-17,708
Closed -$87.5K 10923
2025
Q1
$87.5K Buy
+17,708
New +$56.3K ﹤0.01% 8869
2024
Q4
Sell
-54,167
Closed -$256K 10617
2024
Q3
$256K Buy
54,167
+1,577
+3% +$7.11K ﹤0.01% 8288
2024
Q2
$202K Buy
52,590
+32,815
+166% +$148K ﹤0.01% 8368
2024
Q1
$106K Sell
19,775
-188,400
-91% -$886K ﹤0.01% 8509
2023
Q4
$889K Buy
208,175
+65,047
+45% +$200K ﹤0.01% 5760
2023
Q3
$561K Buy
143,128
+91,897
+179% +$603K ﹤0.01% 6107
2023
Q2
$518K Buy
+51,231
New +$542K ﹤0.01% 6268
2023
Q1
Sell
-22,864
Closed -$214K 9953
2022
Q4
$214K Buy
+22,864
New +$323K ﹤0.01% 7569
2022
Q3
Sell
-11,765
Closed -$155K 10487
2022
Q2
$155K Sell
11,765
-50,726
-81% -$691K ﹤0.01% 8392
2022
Q1
$1.07M Buy
62,491
+25,606
+69% +$434K ﹤0.01% 6004
2021
Q4
$945K Buy
+36,885
New +$1.15M ﹤0.01% 6012

Other funds holding TSVT

Jane Street's TSVT Position: Q2 2025 in Review

Jane Street sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 17,708 shares — an estimated $87.5K sold.

Jane Street first reported a position in TSVT in Q4 2021 and held it in 11 quarters. The position peaked at $1.07M in Q1 2022. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Jane Street reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Jane Street sold 17,708 2seventy bio shares in Q2 2025, an estimated $87.5K.
  • Jane Street first reported a position in 2seventy bio in Q4 2021 and held it in 11 quarters.
  • Jane Street's 2seventy bio position peaked at $1.07M in Q1 2022.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.